The Boston Globe

Business

Boston.com

Bill & Melinda Gates Foundation awards grant to Seventh Sense Biosystems

By Chris Reidy

 |  Globe Staff  

  December 16, 2011

Seventh Sense Biosystems Inc., a Cambridge company developing novel blood sampling technology, has been awarded a $3.28 million grant from the Bill & Melinda Gates Foundation. The company’s technology --- known as Touch Activated Phlebotomy --- can be used in blood-sampling diagnostics. One of the goals of the Gates Foundation is to support efforts that lead to “affordable, easy-to-use tools that can rapidly diagnose diseases and trigger timelier treatment in resource-poor communities.”

Thank you for reading BostonGlobe.com. You have reached the monthly limit for free articles — to continue reading, get unlimited access to BostonGlobe.com now for just 99¢ for 8 weeks.

Unlimited access to BostonGlobe.com includes:

  • The FULL story all day: Enjoy all of the high-quality, in-depth journalism in the print edition of the Boston Globe — plus breaking news that's updated 24/7.
  • A truly reader-friendly format: It's online news that looks and reads just like the newspaper — uncluttered, uninterrupted.
  • Breakthrough technology: The responsive design automatically adapts content so it always reads perfectly on the digital device of your choice.
GET STARTED TODAY

Free access for home delivery subscribers.

Just need to link your home delivery account; one easy step.

Link my home delivery account

BostonGlobe.comSubscriber Log In

Contact us for help